Voyageur Pharmaceuticals Ltd. (TSXV:VM)
0.1650
+0.0100 (6.45%)
Aug 10, 2026, 3:45 PM EST
Voyageur Pharmaceuticals Revenue
Voyageur Pharmaceuticals had revenue of 16.28K CAD in the quarter ending May 31, 2026. This brings the company's revenue in the last twelve months to 47.24K. In the fiscal year ending November 30, 2025, Voyageur Pharmaceuticals had annual revenue of 11.69K.
Revenue (ttm)
47.24K
Revenue Growth
n/a
P/S Ratio
742.67
Revenue / Employee
n/a
Employees
n/a
Market Cap
35.08M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2025 | 11.69K | - | - |
| Nov 30, 2024 | - | - | - |
| Nov 30, 2023 | - | - | - |
| Nov 30, 2022 | - | - | - |
| Nov 30, 2021 | - | - | - |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| iAnthus Capital Holdings | 193.99M |
| Planet 13 Holdings | 134.62M |
| Vext Science | 72.54M |
| Rubicon Organics | 60.76M |
| C21 Investments | 45.53M |
| MediPharm Labs | 43.28M |
| LSL Pharma Group | 28.74M |
| ZYUS Life Sciences | 413.00K |
Voyageur Pharmaceuticals News
- 24 days ago - Voyageur Pharmaceuticals Announces the Engagement of Red Cloud Securities as Market Maker - Newsfile Corp
- 6 weeks ago - Voyageur Pharmaceuticals Engages Fluor to Advance Feasibility Studies for Iodine Production and Integrated Contrast Drug Manufacturing Facility - TheNewswire
- 7 weeks ago - Voyageur Pharmaceuticals Evaluating Three Locations in the United States for Integrated Iodine and Barium Contrast Media Manufacturing Facility, a Multi-Phase Investment Expected to Generate Significant Economic Impact and High-Skilled Jobs; Competitive Site Selection Process Underway - TheNewswire
- 2 months ago - Voyageur Pharmaceuticals Ltd. Submits Multi-Year Area-Based Exploration Permit Application for Bulk Sampling and Feasibility Support at Frances Creek Barite Project - TheNewswire
- 2 months ago - Voyageur Announces Closing Of Non-Brokered Private Placement Pursuant To Listed Issuer Financing Exemption - TheNewswire
- 2 months ago - Voyageur Announces Filing Of Amended And Restated Offering Document - TheNewswire
- 3 months ago - Voyageur Announces Update To Non-Brokered Life Offering - TheNewswire
- 4 months ago - Voyageur Announces Shares for Debt Settlement and Stock Option Repricing - TheNewswire